# Replication of the AMPLIFY Anticoagulant Trial in Healthcare Claims Data

> **NCT04736719** · — · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 19002 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** Apixaban
- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT04736719
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-22
- **Primary completion:** 2021-02-18
- **Final completion:** 2021-02-18
- **Target enrollment:** 19002 (ACTUAL)
- **Last updated:** 2023-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04736719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04736719, "Replication of the AMPLIFY Anticoagulant Trial in Healthcare Claims Data". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04736719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*